Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Messas

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Circulation|July 14, 2017
Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 PatientsCloé Comarmond, Lucie Biard, Marc Lambert, et al.
Physics in Medicine and Biology|October 26, 2020
Feasibility and safety of non-invasive ultrasound therapy (NIUT) on an porcine aortic valveEmmanuel Messas, Mathieu C Rémond, Guillaume Goudot, et al.
European Journal of Preventive Cardiology|January 15, 2026
Cardiovascular risk among Giant cells arteritis patientsAlexis F Guedon, Olivier Espitia, Maxime Beydon, et al.
Journal of Autoimmunity|August 21, 2018
Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patientsAdrien Mirouse, Lucie Biard, Cloé Comarmond, et al.
Circulation|January 25, 2021
Feasibility and Performance of Noninvasive Ultrasound Therapy in Patients With Severe Symptomatic Aortic Valve Stenosis: A First-in-Human StudyEmmanuel Messas, Alexander IJsselmuiden, Guillaume Goudot, et al.
Journal of Cardiovascular Development and Disease|January 29, 2016
Targeted <i>Mybpc3</i> Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve AbnormalitiesDaniel P Judge, Hany Neamatalla, Russell A Norris, et al.
Bulletin Du Cancer|January 22, 2016
[Management of the cardiovascular disease risk during nilotinib treatment in chronic myeloid leukemia: 2015 recommendations from the France Intergroupe des Leucémies Myéloïdes Chroniques]Delphine Rea, Shanti Ame, Aude Charbonnier, et al.
Journal of the American College of Cardiology|September 2, 2017
Effect of Losartan on Mitral Valve Changes After Myocardial InfarctionPhilipp E Bartko, Jacob P Dal-Bianco, J Luis Guerrero, et al.
Angiogenesis|May 28, 2020
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patientsDavid M Smadja, Coralie L Guerin, Richard Chocron, et al.
JACC. Cardiovascular Imaging|September 11, 2020
Proposed Requirements for Cardiovascular Imaging-Related Machine Learning Evaluation (PRIME): A Checklist: Reviewed by the American College of Cardiology Healthcare Innovation CouncilPartho P Sengupta, Sirish Shrestha, Béatrice Berthon, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Circulation|July 14, 2017
Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 PatientsCloé Comarmond, Lucie Biard, Marc Lambert, et al.
Physics in Medicine and Biology|October 26, 2020
Feasibility and safety of non-invasive ultrasound therapy (NIUT) on an porcine aortic valveEmmanuel Messas, Mathieu C Rémond, Guillaume Goudot, et al.
European Journal of Preventive Cardiology|January 15, 2026
Cardiovascular risk among Giant cells arteritis patientsAlexis F Guedon, Olivier Espitia, Maxime Beydon, et al.
Journal of Autoimmunity|August 21, 2018
Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patientsAdrien Mirouse, Lucie Biard, Cloé Comarmond, et al.
Circulation|January 25, 2021
Feasibility and Performance of Noninvasive Ultrasound Therapy in Patients With Severe Symptomatic Aortic Valve Stenosis: A First-in-Human StudyEmmanuel Messas, Alexander IJsselmuiden, Guillaume Goudot, et al.
Journal of Cardiovascular Development and Disease|January 29, 2016
Targeted <i>Mybpc3</i> Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve AbnormalitiesDaniel P Judge, Hany Neamatalla, Russell A Norris, et al.
Bulletin Du Cancer|January 22, 2016
[Management of the cardiovascular disease risk during nilotinib treatment in chronic myeloid leukemia: 2015 recommendations from the France Intergroupe des Leucémies Myéloïdes Chroniques]Delphine Rea, Shanti Ame, Aude Charbonnier, et al.
Journal of the American College of Cardiology|September 2, 2017
Effect of Losartan on Mitral Valve Changes After Myocardial InfarctionPhilipp E Bartko, Jacob P Dal-Bianco, J Luis Guerrero, et al.
Angiogenesis|May 28, 2020
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patientsDavid M Smadja, Coralie L Guerin, Richard Chocron, et al.
JACC. Cardiovascular Imaging|September 11, 2020
Proposed Requirements for Cardiovascular Imaging-Related Machine Learning Evaluation (PRIME): A Checklist: Reviewed by the American College of Cardiology Healthcare Innovation CouncilPartho P Sengupta, Sirish Shrestha, Béatrice Berthon, et al.
Pageof 14